BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 15390249)

  • 1. Cutting balloon angioplasty vs. conventional balloon angioplasty in patients receiving intracoronary brachytherapy for the treatment of in-stent restenosis.
    Fasseas P; Orford JL; Lennon R; O'Neill J; Denktas AE; Panetta CJ; Berger PB; Holmes DR
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):152-7. PubMed ID: 15390249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome following combination of cutting balloon angioplasty and coronary beta-radiation for in-stent restenosis: a report from the RENO registry.
    Roguelov C; Eeckhout E; De Benedetti E; Coucke P; Silber S; Baumgart D; Albiero R; Bonan R; Wegscheider K; Urban P;
    J Invasive Cardiol; 2003 Dec; 15(12):706-9. PubMed ID: 14660823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting balloon angioplasty for treatment of coronary in-stent restenosis: immediate results and 6-month outcomes.
    Chen S; Duan B; Liu Z; Wu X; Wei F; Qian X; Ye F; Fang W; Hu Z; Tamari I; Chen H
    Chin Med J (Engl); 2002 Feb; 115(2):166-9. PubMed ID: 11940323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary beta-radiation for the treatment of patients at very high risk for recurrence of in-stent restenosis: a single center experience.
    Parenti DZ; Marsico F; Tosi G; Catalano G; Maiello L; Milone F; Carcagnì A; Pron PG; Orecchia R; Presbitero P
    Ital Heart J; 2003 Mar; 4(3):199-204. PubMed ID: 12784747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of angiographic and clinical outcomes between rotational atherectomy and cutting balloon angioplasty followed by radiation therapy with a rhenium 188-mercaptoacetyltriglycine-filled balloon in the treatment of diffuse in-stent restenosis.
    Lee SW; Park SW; Hong MK; Kim YH; Han KH; Moon DH; Oh SJ; Lee CW; Kim JJ; Park SJ
    Am Heart J; 2005 Sep; 150(3):577-82. PubMed ID: 16169344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis.
    Kim YH; Lee BK; Park DW; Park KH; Choi BR; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Dec; 98(11):1451-4. PubMed ID: 17126648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis.
    Schukro C; Syeda B; Kirisits C; Schmid R; Pichler P; Pokrajac B; Lang I; Pötter R; Glogar D
    Radiother Oncol; 2007 Jan; 82(1):18-23. PubMed ID: 16971011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent placement compared with balloon angioplasty for obstructed coronary artery disease in Thai elderly patients: initial result and 6 months follow-up.
    Panchavinnin P; Tresukosol D; Phankingthongkum R; Sriyuthasak O; Sahasakul Y; Thongsawas R
    J Med Assoc Thai; 2004 Mar; 87(3):225-32. PubMed ID: 15117037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Are directional coronary atherectomy and Palmaz-Schatz stent more efficacious than conventional balloon angioplasty for treating de novo coronary artery lesions?].
    Nanasato M; Adachi M; Hirayama H; Tsuji Y; Yamada T; Yoshida Y; Yamada K; Miwata S; Tsuboi N; Itoh T; Maeda S; Kuriyama K
    J Cardiol; 1997 Sep; 30(3):117-24. PubMed ID: 9309507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT).
    Albiero R; Silber S; Di Mario C; Cernigliaro C; Battaglia S; Reimers B; Frasheri A; Klauss V; Auge JM; Rubartelli P; Morice MC; Cremonesi A; Schofer J; Bortone A; Colombo A;
    J Am Coll Cardiol; 2004 Mar; 43(6):943-9. PubMed ID: 15028348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compassionate use of intracoronary beta-irradiation for treatment of recurrent in-stent restenosis.
    Sabaté M; Kay IP; Gijzel AL; Wardeh AJ; Van der Giessen WJ; Coen VL; Ligthart JM; Costa MA; Kozuma K; Serrano P; Levendag PC; Serruys PW
    J Invasive Cardiol; 1999 Sep; 11(9):582-8. PubMed ID: 10745603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor outcome in patients treated with brachytherapy for diffuse in-stent restenosis. The role of additional stenting despite prolonged antiplatelet therapy.
    Zavalloni D; Rossi M; Belli G; Scatturin M; Morenghi E; Marsico F; Catalano G; Tosi G; Pagnotta P; Presbitero P
    J Invasive Cardiol; 2005 Nov; 17(11):598-602. PubMed ID: 16264205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of effectiveness and safety of drug-eluting stents versus vascular brachytherapy for saphenous vein graft in-stent restenosis.
    Mishra S; Wolfram RM; Torguson R; Chu WW; Xue Z; Gevorkian N; Donekal S; Chan R; Pichard AD; Satler LF; Kent KM; Waksman R
    Am J Cardiol; 2006 May; 97(9):1303-7. PubMed ID: 16635600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic implications of in-stent restenosis located at the stent edge. Insights from the restenosis intra-stent balloon angioplasty versus elective stenting (RIBS) randomized trial.
    Alfonso F; Melgares R; Mainar V; Lezaún R; Vázquez N; Tascón J; Pomar F; Cequier A; Angel J; Pérez-Vizcayno MJ; Sabaté M; Bañuelos C; Fernández C; García JM;
    Eur Heart J; 2004 Oct; 25(20):1829-35. PubMed ID: 15474698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial.
    Alfonso F; Pérez-Vizcayno MJ; Hernandez R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Mantilla R; Morís C; Cequier A; Sabaté M; Escaned J; Moreno R; Bañuelos C; Suárez A; Macaya C;
    J Am Coll Cardiol; 2006 Jun; 47(11):2152-60. PubMed ID: 16750678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of recurrent in-stent restenosis after beta-radiation: An analysis from the START 40/20 trial.
    Kaneda H; Honda Y; Morino Y; Lansky AJ; Yock PG; Bonan R; Fitzgerald PJ
    J Interv Cardiol; 2006 Oct; 19(5):376-80. PubMed ID: 17020560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparison of early and late outcome of direct and conventional stenting of patients with st elevation myocardial infarction.
    Tacoy G; Yazici GE; Erden M; Timurkaynak T
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):181-6. PubMed ID: 19465441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Debulking for in-stent restenosis in the brachytherapy era: does it still have a role?
    Tuli A; Subramaniyam V; Bakir S; Block PC; Crocker IR
    J Invasive Cardiol; 2003 Apr; 15(4):209-12. PubMed ID: 12668849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and safety of intra-coronary Beta irradiation with 144Ce/Pr for prevention of restenosis after percutaneous transluminal coronary angioplasty of in-stent restenotic lesions.
    Bonvini RF; Hendiri T; Leo G; Aeby N; Noble J; Sigwart U; Verin V
    Acute Card Care; 2006; 8(4):217-23. PubMed ID: 17162548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary revascularisation following intracoronary brachytherapy.
    Sabaté M
    EuroIntervention; 2009 May; 5 Suppl D():D121-6. PubMed ID: 19736060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.